Abstract:Abstract Background Breast cancer is the most prevalent and among the most deadly cancers in females. Patients with breast cancer have highly variable survival lengths, indicating a need to identify prognostic biomarkers for personalized diagnosis and treatment. With the development of new technologies such as next-generation sequencing, multi-omics information are becoming available for a more thorough evaluation of a patient’s condition. In this study, we aim to improve breast cancer overall survival prediction by integrating multi-omics data (e.g., gene expression, DNA methylation, miRNA expression, and copy number variations (CNVs)). Methods Motivated by multi-view learning, we propose a novel strategy to integrate multi-omics data for breast cancer survival prediction by applying complementary and consensus principles. The complementary principle assumes each -omics data contains modality-unique information. To preserve such information, we develop a concatenation autoencoder (ConcatAE) that concatenates the hidden features learned from each modality for integration. The consensus principle assumes that the disagreements among modalities upper bound the model errors. To get rid of the noises or discrepancies among modalities, we develop a cross-modality autoencoder (CrossAE) to maximize the agreement among modalities to achieve a modality-invariant representation. We first validate the effectiveness of our proposed models on the MNIST simulated data. We then apply these models to the TCCA breast cancer multi-omics data for overall survival prediction. Results For breast cancer overall survival prediction, the integration of DNA methylation and miRNA expression achieves the best overall performance of 0.641 ± 0.031 with ConcatAE, and 0.63 ± 0.081 with CrossAE. Both strategies outperform baseline single-modality models using only DNA methylation (0.583 ± 0.058) or miRNA expression (0.616 ± 0.057). Conclusions In conclusion, we achieve improved overall survival prediction performance by utilizing either the complementary or consensus information among multi-omics data. The proposed ConcatAE and CrossAE models can inspire future deep representation-based multi-omics integration techniques. We believe these novel multi-omics integration models can benefit the personalized diagnosis and treatment of breast cancer patients.

A Benchmark Study of Deep Learning-Based Multi-Omics Data Fusion Methods for Cancer.

A review of cancer data fusion methods based on deep learning

Deep learning-based approaches for multi-omics data integration and analysis

MOFNet: A Deep Learning Framework of Integrating Multi-omics Data for Breast Cancer Diagnosis.

DeepFusionCDR: Employing Multi-Omics Integration and Molecule-Specific Transformers for Enhanced Prediction of Cancer Drug Responses

Machine learning for multi-omics data integration in cancer

Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach

Deep Learning Based Multimodal Biomedical Data Fusion: an Overview and Comparative Review

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

Progressively Helical Multi-Omics Data Fusion GCN and Its Application in Lung Adenocarcinoma

DeepOmix: A scalable and interpretable multi-omics deep learning framework and application in cancer survival analysis

Machine-Learning-Based Late Fusion on Multi-Omics and Multi-Scale Data for Non-Small-Cell Lung Cancer Diagnosis

Integration of Multimodal Data from Disparate Sources for Identifying Disease Subtypes

MBFusion: Multi-modal balanced fusion and multi-task learning for cancer diagnosis and prognosis

A comprehensive investigation of multimodal deep learning fusion strategies for breast cancer classification

Multi-omics and deep learning provide a multifaceted view of cancer

Quantifying the advantage of multimodal data fusion for survival prediction in cancer patients

Deep Learning‐Based Multiomics Data Integration Methods for Biomedical Application

A Review of Fusion Methods for Omics and Imaging Data.

Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration

A Multi-modal Fusion Framework Based on Multi-task Correlation Learning for Cancer Prognosis Prediction